Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus Valve System
September 23, 2014 at 16:07 PM EDT
Boston Scientific Corporation (NYSE: BSX) has initiated the REPRISE III clinical trial, a pivotal study to evaluate the safety and ...